CORRECTING and REPLACING Bristol-Myers Squibb to Present at William Blair Conference, Cancer Immunotherapy: A Long-Awaited Reality

Second paragraph, first sentence of the release should read: Materials related to the presentation will be available at http://investor.bms.com.

The corrected release reads:

BRISTOL-MYERS SQUIBB TO PRESENT AT WILLIAM BLAIR CONFERENCE, CANCER IMMUNOTHERAPY: A LONG-AWAITED REALITY

Bristol-Myers Squibb Company (NYSE:BMY) will present at the William Blair Conference, Cancer Immunotherapy: A Long-Awaited Reality, on Thursday, March 31, 2016, in New York. Carl Decicco, senior vice president, Discovery, will make a formal presentation at 8:05 a.m. EDT.

Materials related to the presentation will be available at http://investor.bms.com. An archived edition of the presentation will be available later that day.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, and YouTube.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160324006103/en/